Similar Papers

Paper Title
Journal
Date
Author
Cyclooxygenase inhibitor use during checkpoint immunotherapy and effect on time to progression and overall survival for metastatic melanoma and non-small cell lung cancer patients.
Shang-Jui Wang ... Sinae Kim
Journal of Clinical Oncology | VOL. 38
Shang-Jui Wang, et. al.Shang-Jui Wang ... Sinae Kim
20 May 2020
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Is first-line pembrolizumab appropriate for all patients with metastatic non-squamous histology non-small cell lung cancer patients?
Laura Le ... Ritchell Van Dams
Translational lung cancer research | VOL. 8
Laura Le, et. al.Laura Le ... Ritchell Van Dams
01 Dec 2019
Correlation of homologous recombination deficiency (HRD) score with response to the first-line treatment of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer.
Guo Li ... Lili Zeng
Journal of Clinical Oncology | VOL. 41
Guo Li, et. al.Guo Li ... Lili Zeng
01 Jun 2023
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
Janis M Taube ... Carlo B Bifulco
Journal for ImmunoTherapy of Cancer | VOL. 13
Janis M Taube, et. al.Janis M Taube ... Carlo B Bifulco
08 Jan 2025
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Daniela Esposito ... Luigi Formisano
Journal for ImmunoTherapy of Cancer | VOL. 13
Daniela Esposito, et. al.Daniela Esposito ... Luigi Formisano
01 Jan 2025
CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
Yi Sun ... Yuwen Zhu
Journal for ImmunoTherapy of Cancer | VOL. 13
Yi Sun, et. al.Yi Sun ... Yuwen Zhu
01 Jan 2025
Weal and woe of interleukin-18 in the T cell therapy of cancer
Christoph Kessel ... Hinrich Abken
Journal for ImmunoTherapy of Cancer | VOL. 13
Christoph Kessel, et. al.Christoph Kessel ... Hinrich Abken
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.